Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 09, 2026 20:06 ET | Source: Etienna Bio, Inc.

Etienna Bio Secures Exclusive Worldwide License from UMass Chan Medical School for Novel Adipose-Derived Regenerative Platform

Etienna Bio signs license agreement with UMass Chan Medical Center